U.S. Seeks To Get TPP, ‘Asia Pivot’ Back On Track
This article was originally published in PharmAsia News
Coming off the disastrous loss of the Senate to the Republicans, some are questioning President Barack Obama's ability to finalize the Trans-Pacific Partnership (TPP) free-trade agreement – predicting a rough ride during his trip to Asia this week for various meetings with world leaders, including at the Asia-Pacific Economic Cooperation (APEC) summit in Beijing.
You may also be interested in...
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Drawing on the company’s Latin name, Viatris – the proposed combination of Mylan and Upjohn – has unveiled a logo and branding “capturing the company’s commitment to access, leadership and partnership.”
Having recently signed a gene therapy collaboration with Sarepta and received a positive opinion from the CHMP for its kidney transplant therapy, Sweden's Hansa has now raised a substantial sum in a "multiple times oversubscribed" placing.